1. Home
  2. BMI vs APGE Comparison

BMI vs APGE Comparison

Compare BMI & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BMI

Badger Meter Inc.

HOLD

Current Price

$120.16

Market Cap

4.3B

Sector

Industrials

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$82.77

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMI
APGE
Founded
1905
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.7B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
BMI
APGE
Price
$120.16
$82.77
Analyst Decision
Buy
Strong Buy
Analyst Count
11
13
Target Price
$170.13
$109.67
AVG Volume (30 Days)
781.7K
520.1K
Earning Date
04-17-2026
05-12-2026
Dividend Yield
1.36%
N/A
EPS Growth
13.24
N/A
EPS
0.93
N/A
Revenue
N/A
N/A
Revenue This Year
$5.97
N/A
Revenue Next Year
$7.17
N/A
P/E Ratio
$131.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$112.09
$34.34
52 Week High
$256.08
$95.32

Technical Indicators

Market Signals
Indicator
BMI
APGE
Relative Strength Index (RSI) 36.39 49.11
Support Level $116.97 $73.06
Resistance Level $184.62 $84.56
Average True Range (ATR) 4.53 3.39
MACD 0.49 -0.93
Stochastic Oscillator 53.51 22.86

Price Performance

Historical Comparison
BMI
APGE

About BMI Badger Meter Inc.

Badger Meter is a provider of water management solutions. The company's solutions encompass measurement and control hardware, connectivity and communication, data visualization and software. Badger Meter has globalised operations, with the vast majority of revenue derived from the USA. The company is an innovator in flow measurement, water quality and control products, serving water utilities, municipalities and commercial and industrial customers world-wide.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: